Hear from medical physicist and researcher Anna Bangiri as she shares findings from the CoDe-B-Rad study, exploring quality of life and cognitive changes following stereotactic radiosurgery (SRS) for meningioma.

While radiosurgery is an effective treatment for many people living with benign brain tumours, we still know relatively little about how people experience life in the months and years that follow. Through CoDe-B-Rad, Anna’s research focuses on what matters most to people after treatment, including memory, concentration, thinking, and day-to-day quality of life.

At the heart of this study is the voice of people affected by brain tumours. During the early stages of the research, PRIME worked alongside Anna to bring together people with lived experience whose insights helped shape the study, ensuring it measured outcomes that genuinely matter to patients rather than only clinical measures.

During this webinar, Anna will explain what the study found, how patient involvement influenced the research from the very beginning, and how these findings are helping researchers refine stereotactic radiosurgery to better protect long-term cognitive function and quality of life.

There will also be an opportunity to ask questions and join the discussion.

Whether you took part in the study, have experience of meningioma or stereotactic radiosurgery, or are simply interested in learning how lived experience is shaping future treatment, we would be delighted to welcome you.

Who is this event for?

Primarily people living with, or affected by, meningioma, particularly those who have undergone or are considering stereotactic radiosurgery (SRS). As this is an educational webinar, everyone with an interest in brain tumour research and the role of lived experience in improving treatment is welcome to attend.

Please be advised this meetup will be held via Zoom. You will receive the Zoom link and Meeting ID with your ticket.